MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
Suggest Documents
Citalopram 20 mg, citalopram 40 mg and placebo in the prevention of relapse of major depression.
Daytime wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placebo.
day.
A double-blind placebo-controlled trial of zopiclone 7.5 mg and temazepam 20 mg in insomnia.
Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial.
Citalopram in depression--meta-analysis of intended and unintended effects.
Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study.
Comparison of once daily felodipine 10 mg ER and hydrochlorothiazide 25 mg in the treatment of mild to moderate hypertension.
Danazol in the treatment of menorrhagia: the effect of a 1 month induction dose (200 mg) and 2 month's maintenance therapy (200 mg, 100 mg, 50 mg or placebo).
Acamprosate, citalopram, and alcoholism.
Acamprosate, citalopram, and alcoholism.
Controlling on-demand gastric acidity in obese subjects: a randomized, controlled trial comparing a single dose of 20 mg rabeprazole and 20 mg omeprazole.
Weekend treatment with 20 and 40 mg omeprazole: effect on intragastric pH, fasting and postprandial serum gastrin, and serum pepsinogens.
The use of citalopram for the treatment of cataplexy.
Testing the predictive value of peripheral gene expression for nonremission following citalopram treatment for major depression.
Prognostic subgroups for citalopram response in the STAR*D trial.
A randomized, double-blind study to evaluate the acid-inhibitory effect of vonoprazan (20 mg and 40 mg) in patients with proton-pump inhibitor-resistant erosive esophagitis.
75 mg: randomised double-blind trial in moderate-to-severe acute pain after abdominal hysterectomy.
Single dose treatment of vaginal candidosis: randomised comparison of amorolfine (50 mg and 100 mg) and clotrimazole (500 mg) in patients with vulvovaginal candidosis.
Flunarizine in migraine prophylaxis: efficacy and tolerability of 5 mg and 10 mg dose levels.
A placebo-controlled study of three agomelatine dose regimens (10 mg, 25 mg, 25-50 mg) in patients with major depressive disorder.
Major depressive disorder and response to citalopram treatment in women attending menopause clinic.
Emotion recognition processing as early predictor of response to 8-week citalopram treatment in late-life depression.
Safety of high-dosage citalopram.
Dose response relationship of citalopram 20 mg, citalopram 40 mg and placebo in the treatment of moderate and severe depression.
Dose response relationship of citalopram 20 mg, citalopram 40 mg and placebo in the treatment of moderate and severe depression. - PDF Download Free
3MB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Citalopram 20 mg, citalopram 40 mg and placebo in the prevention of relapse of major depression.
Daytime wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placebo.
day.
A double-blind placebo-controlled trial of zopiclone 7.5 mg and temazepam 20 mg in insomnia.
Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial.
Citalopram in depression--meta-analysis of intended and unintended effects.
Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study.
Comparison of once daily felodipine 10 mg ER and hydrochlorothiazide 25 mg in the treatment of mild to moderate hypertension.
Danazol in the treatment of menorrhagia: the effect of a 1 month induction dose (200 mg) and 2 month's maintenance therapy (200 mg, 100 mg, 50 mg or placebo).
Acamprosate, citalopram, and alcoholism.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms